Subscribe

Dyadic International, Inc. (DYAI)

USD1.22 +0.01 (+0.83%)
US NASDAQ Healthcare Biotechnology
Address 140 Intracoastal Pointe Drive 33477-5094
Jupiter, FL, US
CEO Mark A. Emalfarb
Website dyadic.com
IPO 2008-01-16
CIK 1213809 ISIN US26745T1016

Explore sections of this company profile

Description

Dyadic International, Inc. operates as a U.S.-based biotechnology platform company, specializing in the development, production, and commercialization of enzymes and other proteins. Its core activities are underpinned by a patented and proprietary C1 platform, alongside other advanced technologies. This technological foundation drives their research, development, and commercial endeavors, focusing on the creation and manufacturing of various human and animal vaccines and pharmaceutical products. These offerings span a wide range of biological therapeutics, including virus-like particles (VLPs), antigens, monoclonal, bi-specific, and tri-specific antibodies, Fab antibody fragments, Fc-fusion proteins, biosimilars, biobetters, and diverse therapeutic enzymes and proteins. A key pipeline asset is DYAI-100, a SARS-CoV-2-RBD antigen vaccine candidate. This candidate is currently slated for a first-in-human Phase 1 clinical trial, with the objective of establishing proof of concept for the development of next-generation, multivariant COVID-19 vaccine candidates. Dyadic also maintains several strategic alliances, including a research and development agreement with VTT Technical Research Centre of Finland, Ltd., a strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U., and a collaboration with Syngene International Limited. Established in 1979, the company is headquartered in Jupiter, Florida.

News Sentiment (7d)
78 Positive

Based on only 1 article — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD1.22 +0.01 (+0.83%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
264.8K
Beta
1.15
Float Shares
27.08M
Free Float %
74.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.70% -2.80% -17.32% -14.40% -21.49% -24.41% -32.97% -63.19% -81.50% -58.21% -11.19%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (2 ratings, all time) Buy
Price Targets & DCF
Current price
1.22
Low 3.00 +145.9%
Consensus 3.00 +145.9%
Median 3.00 +145.9%
High 3.00 +145.9%
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year 1
3.00
+145.9%
All Time 1
3.00
+145.9%
Quality scores
Altman Z-Score
-17.02
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    -11.6% Q1'26: +506.7% (vs Q1'25)
  • EPS growth Biotechnology: +29.7%
    -15.0% Q1'26: +26.3% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
    -224.6% Q1'26: -176.7% (vs Q1'25)
  • EBIT margin Biotechnology: +0.0%
    -231.2% Q1'26: +0.0% (vs Q1'25)
  • ROIC Biotechnology: -16.1%
    Q1'26: +0.0% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +11.3% Q1'26: +21.8% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.71× Q1'26: -0.94× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.17) × ERP
WACC = 82% × Ke + 18% × Kd (9.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 1.22
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
2 Rev. Ana.
2 EPS Ana.
Dec 2027
2 Rev. Ana.
2 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Dec 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
1.30M
est: 766.0K (+69.1%)
1.68M
est: 1.63M (+3.4%)
1.60M
est: 1.16M (+38.3%)
2.40M
est: 2.27M (+6.0%)
2.93M
est: 3.65M (-19.7%)
2.90M
est: 1.80M (+60.7%)
3.50M
est: 4.30M (-18.7%)
3.09M
est: 3.86M (-19.9%)
6.74M
4.98M – 8.40M
+74.7% YoY
13.50M
9.98M – 16.84M
+100.4% YoY
19.67M
14.54M – 24.53M
+45.7% YoY
19.74M
14.59M – 24.61M
+0.3% YoY
EBITDA
-7.55M
est: -766.0K (-885.8%)
est: -1.63M (+100.0%)
-9.96M
est: -1.16M (-760.4%)
-11.14M
est: -2.27M (-391.4%)
-10.12M
est: -3.65M (-177.1%)
-8.15M
est: -1.80M (-351.9%)
-5.38M
est: -4.30M (-25.1%)
-7.15M
est: -3.86M (-85.3%)
-6.74M
-8.40M – -4.98M
-74.7% YoY
-13.50M
-16.84M – -9.98M
-100.4% YoY
-19.67M
-24.53M – -14.54M
-45.7% YoY
-19.74M
-24.61M – -14.59M
-0.3% YoY
EBIT
-7.57M
est: -766.0K (-888.5%)
-9.25M
est: -1.63M (-469.4%)
-9.96M
est: -1.16M (-760.4%)
-14.63M
est: -2.27M (-545.4%)
-10.12M
est: -3.65M (-177.1%)
-8.19M
est: -1.80M (-354.0%)
-5.38M
est: -4.30M (-25.1%)
-7.15M
est: -3.86M (-85.3%)
-6.74M
-8.40M – -4.98M
-74.7% YoY
-13.50M
-16.84M – -9.98M
-100.4% YoY
-19.67M
-24.53M – -14.54M
-45.7% YoY
-19.74M
-24.61M – -14.59M
-0.3% YoY
Net Income
-5.69M
est: -7.33M (+22.3%)
-8.31M
est: -9.38M (+11.4%)
-9.33M
est: -10.26M (+9.1%)
-13.07M
est: -10.46M (-25.0%)
-9.74M
est: -10.48M (+7.1%)
-6.80M
est: -7.74M (+12.2%)
-5.81M
est: -5.58M (-4.2%)
-7.36M
est: -7.36M (+0.0%)
-3.43M
-3.88M – -1.94M
+53.4% YoY
323.4K
215.7K – 431.0K
+109.4% YoY
7.83M
5.18M – 10.34M
+2,321.4% YoY
7.83M
5.18M – 10.34M
+0.0% YoY
SGA
4.52M
est: 1.92M (+135.5%)
5.52M
est: 4.08M (+35.4%)
6.08M
est: 2.90M (+109.5%)
6.70M
est: 5.68M (+17.8%)
6.42M
est: 9.15M (-29.8%)
5.82M
est: 3.83M (+52.0%)
6.13M
est: 9.12M (-32.7%)
5.76M
est: 8.18M (-29.5%)
14.29M
10.56M – 17.82M
+74.7% YoY
28.64M
21.17M – 35.71M
+100.4% YoY
41.71M
30.84M – 52.02M
+45.7% YoY
41.85M
30.95M – 52.19M
+0.3% YoY
EPS
-0.21
est: -0.25 (+16.0%)
-0.31
est: -0.32 (+3.1%)
-0.34
est: -0.35 (+2.9%)
-0.47
est: -0.36 (-31.8%)
-0.34
est: -0.34 (+0.0%)
-0.24
est: -0.27 (+10.2%)
-0.20
est: -0.18 (-11.1%)
-0.23
est: -0.23 (-2.2%)
-0.09
-0.12 – -0.06
+60.0% YoY
0.01
0.01 – 0.01
+111.1% YoY
0.24
0.16 – 0.32
+2,300.0% YoY
0.24
0.16 – 0.32
+0.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-12 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-01 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-5.71M
OE per share TTM
-0.17
Owner's Yield
-22.06%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
1.5%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
14
Total invested
2.11M
Insider transactions (90d)
0
Beneficial owners (>5%)
18
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Barry M. Kitt 16.39M 52.40% 16.39M 1.79M 10.00 IN United States 2008-02-15
2 David M. Knott 16.39M 52.40% 16.39M 1.14M 10.00 IN United States 2008-02-15
3 The Pinnacle Fund, L.P. 16.39M 52.40% 16.39M 1.79M 10.00 PN Texas 2008-02-15
4 A. Emalfarb 7.10M 24.50% 7.10M 7.10M IN States of America 2006-02-07
5 Mark A. Emalfarb 5.16M 17.90% 5.16M 5.16M IN United States America 2022-02-14
6 Trust U/A/D February 28, 1996 4.77M 16.00% 4.77M 4.77M OO States of America 2007-02-07
7 Francisco Trust under agreement dated February 28, 1996 3.55M 12.60% 3.55M 3.55M IN Illinois 2022-02-28
8 36-4518466 2.14M 8.60% CO : 2006-11-17
9 David A. Hurwitz 2.03M 5.05% 2.03M IN Delaware 2016-04-06
10 John T. Bird 2.03M 5.05% 2.03M IN Delaware 2016-04-06
11 Neil H. Koffler 2.03M 5.05% 2.03M IN Delaware 2016-04-06
12 Peter M. Collery 2.03M 5.05% 2.03M IN Delaware 2016-04-06
13 SC Fundamental LLC 2.03M 5.05% 2.03M PN Delaware 2016-04-06
14 Value Fund, L.P. 2.03M 5.05% 2.03M PN Delaware 2016-04-06
15 52-0556948 1.76M 5.80% 150.3K 1.76M IA MARYLAND 2008-02-13
16 BANDERA PARTNERS LLC 1.57M 5.60% 1.57M IA, OO 2022-02-14
17 GREGORY BYLINSKY 1.57M 5.60% 1.57M HC, IN 2022-02-14
18 JEFFERSON GRAMM 1.57M 5.60% 1.57M HC, IN 2022-02-14

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
14
-24 vs prev Q
New positions
4
Closed positions
28
Increased
4
Reduced
3
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 APIS CAPITAL ADVISORS, LLC 1.49M -50.0K (-3.2%) 1.40M -416.6K (-22.9%) 4.32% -0.798 pp 0.24% -0.157 pp USD1.18 -20.3% 2 qtrs
2 VANGUARD GROUP INC 915.0K +— (+0.0%) 860.1K -219.6K (-20.3%) 2.65% -0.388 pp 0.00% +0.000 pp USD5.39 -82.6% 27 qtrs
3 CHAPIN DAVIS, INC. 888.0K -44.0K (-4.7%) 834.7K -265.0K (-24.1%) 2.57% -0.523 pp 0.20% -0.074 pp USD1.23 -23.6% 13 qtrs
4 PERKINS CAPITAL MANAGEMENT INC 344.4K -3.6K (-1.0%) 323.7K -87.0K (-21.2%) 1.00% -0.158 pp 0.26% -0.105 pp USD2.02 -53.5% 22 qtrs
5 TRUIST FINANCIAL CORP 326.2K +— (+0.0%) 306.6K -78.3K (-20.3%) 0.95% -0.138 pp 0.00% 0.000 pp USD1.62 -42.0% 5 qtrs
6 GEODE CAPITAL MANAGEMENT, LLC 301.7K +36.3K (+13.7%) 283.6K -29.6K (-9.5%) 0.87% -0.008 pp 0.00% +0.000 pp USD5.01 -81.2% 27 qtrs
7 BLACKROCK, INC. 269.0K +14.5K (+5.7%) 252.8K -47.5K (-15.8%) 0.78% -0.066 pp 0.00% +0.000 pp USD1.03 -8.7% 6 qtrs
8 RENAISSANCE TECHNOLOGIES LLC 147.6K -17.5K (-10.6%) 138.8K -56.1K (-28.8%) 0.43% -0.121 pp 0.00% +0.000 pp USD1.25 -24.8% 10 qtrs
9 LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 110.1K -50.6K (-31.5%) 103.5K -86.1K (-45.4%) 0.32% -0.215 pp 0.01% -0.005 pp USD1.18 -20.3% 2 qtrs
10 SAGE MOUNTAIN ADVISORS LLC 106.6K +— (+0.0%) 100.2K -25.6K (-20.3%) 0.31% -0.045 pp 0.01% -0.002 pp USD5.38 -82.5% 21 qtrs
11 MARATHON CAPITAL MANAGEMENT 85.0K +50.0K (+142.9%) 79.9K +38.6K (+93.5%) 0.25% +0.130 pp 0.02% +0.008 pp USD1.04 -9.6% 2 qtrs
12 HIGHTOWER ADVISORS, LLC 79.5K +— (+0.0%) 74.7K -19.1K (-20.3%) 0.23% -0.034 pp 0.00% +0.000 pp USD1.66 -43.4% 8 qtrs
13 NORTHERN TRUST CORP 67.9K +— (+0.0%) 63.9K -16.3K (-20.3%) 0.20% -0.029 pp 0.00% +0.000 pp USD6.98 -86.5% 27 qtrs
14 AE WEALTH MANAGEMENT LLC 53.8K +— (+0.0%) 50.5K -12.9K (-20.3%) 0.16% -0.023 pp 0.00% 0.000 pp USD1.76 -46.6% 11 qtrs
15 ALPHACORE CAPITAL LLC 50.8K +— (+0.0%) 47.7K -12.2K (-20.3%) 0.15% -0.022 pp 0.00% -0.001 pp USD0.99 -5.1% 3 qtrs
16 LPL FINANCIAL LLC 44.9K +— (+0.0%) 42.2K -10.8K (-20.3%) 0.13% -0.019 pp 0.00% +0.000 pp USD1.19 -21.0% 7 qtrs
17 STATE STREET CORP 42.6K +— (+0.0%) 40.0K -10.2K (-20.3%) 0.12% -0.018 pp 0.00% +0.000 pp USD7.80 -87.9% 23 qtrs
18 PEKIN HARDY STRAUSS, INC. 41.7K +— (+0.0%) 39.2K -10.0K (-20.3%) 0.12% -0.018 pp 0.00% -0.001 pp USD5.91 -84.1% 27 qtrs
19 XTX TOPCO LTD 36.3K +11.5K (+46.7%) 34.1K +4.9K (+16.8%) 0.11% +0.023 pp 0.00% -0.001 pp USD1.13 -16.8% 6 qtrs
20 INLET PRIVATE WEALTH, LLC 30.0K +— (+0.0%) 28.2K -7.2K (-20.3%) 0.09% -0.013 pp 0.01% -0.001 pp USD1.75 -46.3% 5 qtrs
21 ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC 30.0K +— (+0.0%) 28.2K -7.2K (-20.3%) 0.09% -0.013 pp 0.00% 0.000 pp USD1.53 -38.6% 7 qtrs
22 COMMONWEALTH EQUITY SERVICES, LLC 22.6K -3.8K (-14.4%) 21.2K -9.8K (-31.5%) 0.07% -0.022 pp 0.00% +0.000 pp USD1.64 -42.7% 8 qtrs
23 TWO SIGMA SECURITIES, LLC 20.8K +20.8K (+100.0%) 19.5K +19.5K (+100.0%) 0.06% +0.060 pp 0.00% +0.003 pp USD0.94 +0.0% 1 qtrs NEW
24 CAPTRUST FINANCIAL ADVISORS 15.0K +— (+0.0%) 14.1K -3.6K (-20.3%) 0.04% -0.006 pp 0.00% +0.000 pp USD1.78 -47.2% 16 qtrs
25 TRAPHAGEN INVESTMENT ADVISORS LLC 13.0K +13.0K (+100.0%) 12.2K +12.2K (+100.0%) 0.04% +0.038 pp 0.00% +0.001 pp USD0.94 +0.0% 1 qtrs NEW
26 UBS GROUP AG 11.5K +11.5K (+1,148,600.0%) 10.8K +10.8K (+1,079,700.0%) 0.03% +0.033 pp 0.00% +0.000 pp USD0.94 +0.0% 2 qtrs
27 HANCOCK WHITNEY CORP 11.1K +— (+0.0%) 10.4K -2.7K (-20.3%) 0.03% -0.005 pp 0.00% 0.000 pp USD0.99 -5.1% 3 qtrs
28 HOEY INVESTMENTS, INC 9.8K +— (+0.0%) 9.3K -2.4K (-20.3%) 0.03% -0.004 pp 0.00% 0.000 pp USD1.67 -43.7% 8 qtrs
29 PNC FINANCIAL SERVICES GROUP, INC. 4.0K +— (+0.0%) 3.8K -960.0 (-20.3%) 0.01% -0.002 pp 0.00% +0.000 pp USD5.13 -81.7% 18 qtrs
30 ROYAL BANK OF CANADA 691.00 +691.0 (+100.0%) 1.0K +1.0K (+100.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD0.94 +0.0% 1 qtrs NEW
31 MORGAN STANLEY 227.00 -5.2K (-95.8%) 213.00 -6.2K (-96.7%) 0.00% -0.017 pp 0.00% +0.000 pp USD1.13 -16.8% 27 qtrs
32 WELLS FARGO & COMPANY/MN 178.00 +— (+0.0%) 168.00 -42.0 (-20.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD1.25 -24.8% 25 qtrs
33 SIMPLEX TRADING, LLC 88.00 +88.0 (+100.0%) 82.00 +82.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.93 +1.1% 5 qtrs
34 BARCLAYS PLC 72.00 +— (+0.0%) 68.00 -7.0 (-9.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.75 -46.3% 9 qtrs
35 BNP PARIBAS ARBITRAGE, SNC 69.00 +— (+0.0%) 65.00 -16.0 (-19.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.68 -87.8% 23 qtrs
36 JPMORGAN CHASE & CO 29.00 +— (+0.0%) 27.00 -7.0 (-20.6%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.48 -36.5% 12 qtrs
37 BANK OF AMERICA CORP /DE/ 17.00 +2.0 (+13.3%) 16.00 -2.0 (-11.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD1.47 -36.1% 27 qtrs
38 CITIGROUP INC 1.00 +1.0 (+100.0%) 1.00 +1.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 1 qtrs NEW
39 CI PRIVATE WEALTH, LLC -250.0K (-100.0%) -295.0K (-100.0%) 0.00% -0.831 pp 0.00% -0.001 pp USD 2 qtrs SOLD
40 CITADEL ADVISORS LLC -13.0K (-100.0%) -15.4K (-100.0%) 0.00% -0.043 pp 0.00% +0.000 pp USD 2 qtrs SOLD
41 GROUP ONE TRADING, L.P. -1.5K (-100.0%) -1.8K (-100.0%) 0.00% -0.005 pp 0.00% +0.000 pp USD 2 qtrs SOLD
42 JANE STREET GROUP, LLC -19.2K (-100.0%) -22.7K (-100.0%) 0.00% -0.064 pp 0.00% +0.000 pp USD 2 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 11 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Vanguard Extended Market ETF VXF 0.00% 272.2K 0.05%
2 Vanguard U.S. Total Market Shares Index ETF VTS.AX 0.00% 999.61 0.03%
3 Vanguard U.S. Total Market Index ETF VUN.TO 0.00% 2.7K 0.17%
4 Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO 0.00% 202.73 0.17%
5 Vanguard Total Stock Market ETF VTI 0.00% 469.0K 0.03%
6 Vanguard All-Equity ETF Portfolio VEQT.TO 0.00% 1.0K 0.22%
7 Vanguard Growth ETF Portfolio VGRO.TO 0.00% 559.49 0.22%
8 Vanguard Balanced ETF Portfolio VBAL.TO 0.00% 225.96 0.22%
9 Vanguard Conservative ETF Portfolio VCNS.TO 0.00% 24.94 0.22%
10 Vanguard Conservative Income ETF Portfolio VCIP.TO 0.00% 3.51 0.22%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
26.0K
Shares disposed
Cash buys
2.00
Cash sales
Net activity
+26,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-01-02 TCHELET RONEN Officer A-Award A Common Stock 18,064 0.00 50,897 D
2026-01-02 Rawson Ping Wang Officer A-Award A Stock Option 47,250 0.94 44.4K 47,250 D
2026-01-02 Lucy Patrick K. Director M-Exempt D Restricted Stock Unit 21,552 0.00 0 D
2026-01-02 Kaye Jack Director A-Award A Restricted Stock Unit 39,894 0.00 39,894 D
2026-01-02 Hazelton Joseph P Officer A-Award A Stock Option 67,250 0.94 63.2K 67,250 D
2026-01-02 HERBST SETH Director M-Exempt D Restricted Stock Unit 21,552 0.00 0 D
2026-01-02 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Stock Option 126,000 0.94 118.4K 126,000 D
2025-12-23 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Senior Secured Convertible Promissory Note due Dec 31, 2027 0 1.05 0 I
2025-09-15 EMALFARB MARK A Director / Officer / 10% Owner P-Purchase A Senior Secured Convertible Promissory Note due March 8, 2027 0 1.40 0 I
2025-08-01 Hazelton Joseph P Officer P-Purchase A Common Stock 26,000 0.95 24.7K 155,340 D
2025-06-20 Tarnok Michael P. Director M-Exempt A Common Stock 10,776 0.00 281,033 D
2025-06-20 Bose Arindam Director M-Exempt A Common Stock 10,776 0.00 61,535 D
2025-05-30 Hazelton Joseph P Officer A-Award A Stock Option 25,000 1.04 26.0K 25,000 D
2025-03-05 Kaye Jack Director M-Exempt A Common Stock 22,500 1.33 29.9K 87,166 D
2025-01-06 HERBST SETH Director M-Exempt A Common Stock 6,250 0.97 6.1K 180,759 D
2025-01-02 Tarnok Michael P. Director A-Award A Stock Option 25,000 1.74 43.5K 25,000 D
2025-01-02 TCHELET RONEN Officer A-Award A Common Stock 8,980 0.00 32,833 D
2025-01-02 Rawson Ping Wang Officer A-Award A Common Stock 20,776 0.00 140,993 D
2025-01-02 Lucy Patrick K. Director M-Exempt D Restricted Stock Unit 23,585 0.00 0 D
2025-01-02 Kaye Jack Director A-Award A Restricted Stock Unit 21,552 0.00 21,552 D
2025-01-02 Hazelton Joseph P Officer A-Award A Common Stock 30,172 0.00 129,340 D
2025-01-02 HERBST SETH Director M-Exempt D Restricted Stock Unit 23,585 0.00 0 D
2025-01-02 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Common Stock 73,111 0.00 4,730,058 D
2025-01-02 Bose Arindam Director M-Exempt D Restricted Stock Unit 23,585 0.00 0 D
2024-11-22 Tarnok Michael P. Director M-Exempt A Common Stock 18,750 0.97 18.2K 246,672 D
2024-06-11 Buckland Barry Director D-Return D Restricted Stock Unit 11,792 0.00 38,967
2024-05-21 Tarnok Michael P. Director F-InKind D Common Stock 24,431 1.67 40.8K 221,672
2024-04-11 Tarnok Michael P. Director D-Return D Stock Option 13,125 1.59 20.9K 54,375
2024-04-11 Lucy Patrick K. Director A-Award A Stock Option 13,125 1.84 24.2K 13,125
2024-04-11 Hazelton Joseph P Officer A-Award A Stock Option 20,000 1.84 36.8K 20,000
2024-03-13 TCHELET RONEN Officer A-Award A Common Stock 11,169 0.00 23,853
2024-03-13 Rawson Ping Wang Officer A-Award A Common Stock 35,366 0.00 120,217
2024-03-13 Hazelton Joseph P Officer A-Award A Common Stock 41,720 0.00 99,168
2024-03-13 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Common Stock 124,454 0.00 4,656,947
2024-01-06 HERBST SETH Director M-Exempt D Stock Option 6,250 0.97 6.1K 0 D
2024-01-03 Tarnok Michael P. Director M-Exempt D Restricted Stock Unit 27,174 0.00 0
2024-01-03 Lucy Patrick K. Director M-Exempt D Restricted Stock Unit 27,174 0.00 0
2024-01-03 Kaye Jack Director M-Exempt A Common Stock 27,174 0.00 33,581
2024-01-03 HERBST SETH Director M-Exempt D Restricted Stock Unit 27,174 0.00 0
2024-01-03 Buckland Barry Director M-Exempt A Common Stock 27,174 0.00 27,174
2024-01-03 Bose Arindam Director M-Exempt D Restricted Stock Unit 27,174 0.00 0
2024-01-02 Tarnok Michael P. Director A-Award A Stock Option 67,500 1.59 107.3K 67,500
2024-01-02 TCHELET RONEN Officer A-Award A Stock Option 37,500 1.59 59.6K 37,500
2024-01-02 Rawson Ping Wang Officer A-Award A Stock Option 75,000 1.59 119.3K 75,000
2024-01-02 Lucy Patrick K. Director A-Award A Stock Option 50,000 1.59 79.5K 50,000
2024-01-02 Kaye Jack Director A-Award A Stock Option 67,500 1.59 107.3K 67,500
2024-01-02 Hazelton Joseph P Officer A-Award A Stock Option 75,000 1.59 119.3K 75,000
2024-01-02 HERBST SETH Director A-Award A Restricted Stock Unit 23,585 0.00 23,585
2024-01-02 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Stock Option 200,000 1.59 318.0K 200,000
2024-01-02 Buckland Barry Director A-Award A Restricted Stock Unit 23,585 0.00 23,585
2024-01-02 Bose Arindam Director A-Award A Stock Option 67,500 1.59 107.3K 67,500
2023-01-03 Tarnok Michael P. Director A-Award A Restricted Stock Unit 27,174 0.00 27,174
2023-01-03 TCHELET RONEN Officer A-Award A Common Stock 12,684 1.38 17.5K 12,684
2023-01-03 Rawson Ping Wang Officer A-Award A Stock Option 75,000 0.00 75,000
2023-01-03 Lucy Patrick K. Director A-Award A Restricted Stock Unit 27,174 0.00 27,174
2023-01-03 Kaye Jack Director A-Award A Stock Option 52,500 0.00 52,500
2023-01-03 Hazelton Joseph P Officer A-Award A Common Stock 57,448 1.38 79.3K 57,448
2023-01-03 HERBST SETH Director A-Award A Stock Option 35,000 0.00 35,000
2023-01-03 EMALFARB MARK A Officer A-Award A Stock Option 200,000 0.00 200,000
2023-01-03 Buckland Barry Director A-Award A Stock Option 35,000 0.00 35,000
2023-01-03 Bose Arindam Director A-Award A Stock Option 52,500 0.00 52,500
2023-01-02 Tarnok Michael P. Director D Stock Option 9,375 1.87 17.5K 0
2023-01-02 Rawson Ping Wang Officer D Stock Option 25,000 1.87 46.8K 0
2023-01-02 Kaye Jack Director D Stock Option 14,063 1.87 26.3K 0
2023-01-02 HERBST SETH Director D Stock Option 9,375 1.87 17.5K 0
2023-01-02 Buckland Barry Director D Stock Option 9,375 1.87 17.5K 0
2023-01-02 Bose Arindam Director D Stock Option 14,063 1.87 26.3K 0
2022-07-08 TCHELET RONEN Officer M-Exempt D Stock Option 1,089 1.57 1.7K 41,057
2022-07-07 TCHELET RONEN Officer M-Exempt D Stock Option 7,854 1.57 12.3K 42,146
2022-06-10 Tarnok Michael P. Director A-Award A Stock Option 25,000 0.00 25,000
2022-06-10 Lucy Patrick K. Director A-Award A Stock Option 25,000 0.00 25,000
2022-06-10 Kaye Jack Director A-Award A Stock Option 25,000 0.00 25,000
2022-06-10 HERBST SETH Director A-Award A Stock Option 25,000 2.60 65.0K 25,000
2022-06-10 Buckland Barry Director A-Award A Stock Option 25,000 2.60 65.0K 25,000
2022-06-10 Bose Arindam Director A-Award A Stock Option 25,000 0.00 25,000
2022-03-19 Rawson Ping Wang Officer D Stock Option 12,500 1.44 18.0K 0
2022-01-28 HERBST SETH Director M-Exempt A Common Stock 25,000 1.21 30.3K 25,000
2022-01-03 Tarnok Michael P. Director A-Award A Stock Option 52,500 4.81 252.5K 52,500
2022-01-03 TCHELET RONEN Officer A-Award A Stock Option 37,500 4.81 180.4K 37,500
2022-01-03 Rawson Ping Wang Officer A-Award A Stock Option 75,000 4.81 360.8K 75,000
2022-01-03 Lucy Patrick K. Director A-Award A Stock Option 50,000 4.81 240.5K 50,000
2022-01-03 Kaye Jack Director A-Award A Stock Option 52,500 4.81 252.5K 52,500
2022-01-03 Hazelton Joseph P Officer A-Award A Stock Option 12,500 4.81 60.1K 12,500
2022-01-03 HERBST SETH Director A-Award A Stock Option 35,000 4.81 168.4K 35,000
2022-01-03 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Stock Option 200,000 4.81 962.0K 200,000
2022-01-03 Buckland Barry Director D Stock Option 9,375 1.39 13.0K 0
2022-01-03 Bose Arindam Director A-Award A Stock Option 52,500 4.81 252.5K 52,500
2022-01-02 Tarnok Michael P. Director D Stock Option 9,375 1.39 13.0K 0
2022-01-02 Rawson Ping Wang Officer D Stock Option 7,500 1.39 10.4K 0
2022-01-02 Kaye Jack Director D Stock Option 9,375 1.39 13.0K 0
2022-01-02 HERBST SETH Director D Stock Option 9,375 1.39 13.0K 0
2022-01-02 Bose Arindam Director D Stock Option 9,375 1.39 13.0K 0
2021-12-23 EMALFARB MARK A Director / Officer / 10% Owner M-Exempt A Common Stock 150,000 1.63 244.5K 4,394,015
2021-12-22 EMALFARB MARK A Director / Officer / 10% Owner S-Sale D Common Stock 35,649 4.12 146.9K 4,272,782
2021-12-21 EMALFARB MARK A Director / Officer / 10% Owner S-Sale D Common Stock 26,486 4.33 114.7K 4,308,431
2021-11-09 Hazelton Joseph P Officer 0 0.00 0
2021-08-28 Bose Arindam Director D Stock Option 9,375 1.43 13.4K 0
2021-08-11 Francisco Trust under agreement dated February 28, 1996 10% Owner S-Sale D Common Stock 150,000 5.14 771.0K 3,548,528
2021-07-27 Francisco Trust under agreement dated February 28, 1996 10% Owner S-Sale D Common Stock 25,000 103,965.00 2.60B 3,698,528
2021-06-21 EMALFARB MARK A Director / Officer / 10% Owner D Stock Option 400,000 1.67 668.0K 0
2021-06-09 EMALFARB MARK A Director / Officer / 10% Owner M-Exempt D Stock Option 100,000 1.67 167.0K 0
2021-06-08 EMALFARB MARK A Director / Officer / 10% Owner S-Sale D Common Stock 30,000 3.82 114.6K 4,257,917
2021-06-07 EMALFARB MARK A Director / Officer / 10% Owner S-Sale D Common Stock 44,000 3.95 173.8K 4,287,917
2021-06-04 EMALFARB MARK A Director / Officer / 10% Owner M-Exempt A Common Stock 400,000 1.67 668.0K 4,331,917
2021-06-03 Rawson Ping Wang Officer P-Purchase A Common Stock 1,350 3.60 4.9K 35,850
2021-06-03 EMALFARB MARK A Director / Officer / 10% Owner S-Sale D Common Stock 26,721 3.61 96.5K 4,063,917
2021-06-02 Rawson Ping Wang Officer P-Purchase A Common Stock 174 3.89 676.86 6,330
2021-06-02 EMALFARB MARK A Director / Officer / 10% Owner S-Sale D Common Stock 76,349 3.74 285.5K 4,090,638
2021-01-29 HERBST SETH Director M-Exempt A Common Stock 50,000 1.93 96.5K 50,000
2021-01-08 Lucy Patrick K. Director 0 0.00 0
2021-01-04 Tarnok Michael P. Director A-Award A Stock Option 52,500 5.16 270.9K 52,500
2021-01-04 TCHELET RONEN Officer A-Award A Stock Option 67,500 5.16 348.3K 67,500
2021-01-04 Rawson Ping Wang Officer A-Award A Stock Option 75,000 5.16 387.0K 75,000
2021-01-04 Kaye Jack Director A-Award A Stock Option 52,500 5.16 270.9K 52,500
2021-01-04 Jones Matthew S. Officer A-Award A Stock Option 75,000 5.16 387.0K 75,000
2021-01-04 HERBST SETH Director A-Award A Stock Option 35,000 5.16 180.6K 35,000
2021-01-04 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Stock Option 200,000 5.16 1.03M 200,000
2021-01-04 Buckland Barry Director A-Award A Stock Option 35,000 5.16 180.6K 35,000
2021-01-04 Bose Arindam Director A-Award A Stock Option 52,500 5.16 270.9K 52,500
2021-01-03 Tarnok Michael P. Director D Stock Option 9,375 1.63 15.3K 0
2021-01-03 Rawson Ping Wang Officer D Stock Option 2,972 1.63 4.8K 0
2021-01-03 Kaye Jack Director D Stock Option 9,375 1.63 15.3K 0
2021-01-03 HERBST SETH Director D Stock Option 9,375 1.63 15.3K 0
2021-01-03 Bose Arindam Director D Stock Option 9,375 1.63 15.3K 0
2020-08-15 Bose Arindam Director D Stock Option 5,625 1.44 8.1K 0
2020-06-27 Rawson Ping Wang Officer D Stock Option 6,250 1.62 10.1K 0
2020-06-07 Tarnok Michael P. Director D Stock Option 4,687 1.67 7.8K 0
2020-06-07 Kaye Jack Director D Stock Option 4,687 1.67 7.8K 0
2020-06-07 HERBST SETH Director D Stock Option 4,687 1.67 7.8K 0
2020-01-19 TCHELET RONEN Officer D Stock Option 50,000 1.57 78.5K 0
2020-01-04 Tarnok Michael P. Director D Stock Option 4,687 1.82 8.5K 0
2020-01-04 Kaye Jack Director D Stock Option 4,687 1.82 8.5K 0
2020-01-04 HERBST SETH Director D Stock Option 4,687 1.82 8.5K 0
2020-01-02 Tarnok Michael P. Director A-Award A Stock Option 75,000 5.27 395.3K 75,000
2020-01-02 TCHELET RONEN Officer D Stock Option 100,000 1.87 187.0K 0
2020-01-02 Rawson Ping Wang Officer A-Award A Stock Option 75,000 5.27 395.3K 75,000
2020-01-02 Kaye Jack Director A-Award A Stock Option 75,000 5.27 395.3K 75,000
2020-01-02 Jones Matthew S. Officer D Stock Option 100,000 1.87 187.0K 0
2020-01-02 HERBST SETH Director A-Award A Stock Option 50,000 5.27 263.5K 50,000
2020-01-02 EMALFARB MARK A Director / Officer / 10% Owner A-Award A Stock Option 300,000 5.27 1.58M 300,000
2020-01-02 Buckland Barry Director A-Award A Stock Option 50,000 5.27 263.5K 50,000
2020-01-02 Bose Arindam Director A-Award A Stock Option 75,000 5.27 395.3K 75,000
2019-12-11 TCHELET RONEN Officer M-Exempt A Common Stock 4,575 1.41 6.5K 10,000
2019-12-10 TCHELET RONEN Officer S-Sale D Common Stock 5,425 5.84 31.7K 4,575
2019-12-03 Buckland Barry Director M-Exempt A Common Stock 2,500 1.39 3.5K 15,000
2019-11-28 Rawson Ping Wang Officer D Stock Option 125,000 1.76 220.0K 0
2019-11-11 TCHELET RONEN Officer M-Exempt D Stock Option 10,000 1.41 14.1K 10,000
2019-10-11 TCHELET RONEN Officer M-Exempt A Common Stock 5,218 1.41 7.4K 5,218
2019-10-10 TCHELET RONEN Officer M-Exempt A Common Stock 4,782 1.41 6.7K 4,782
2019-09-10 TCHELET RONEN Officer M-Exempt D Stock Option 10,000 1.41 14.1K 30,000
2019-08-13 TCHELET RONEN Officer S-Sale D Common Stock 6,300 5.75 36.2K 0
2019-08-12 TCHELET RONEN Officer S-Sale D Common Stock 3,700 5.72 21.2K 0
2019-07-10 TCHELET RONEN Officer M-Exempt D Stock Option 10,000 1.41 14.1K 50,000
2019-06-28 Rawson Ping Wang Officer A-Award A Stock Option 25,000 6.26 156.5K 25,000
2019-06-25 Tarnok Michael P. Director A-Award A Stock Option 25,000 5.83 145.8K 25,000
2019-06-25 Kaye Jack Director A-Award A Stock Option 25,000 5.83 145.8K 25,000
2019-06-25 Bose Arindam Director A-Award A Stock Option 25,000 5.83 145.8K 25,000
2019-06-18 TCHELET RONEN Officer M-Exempt A Common Stock 2,084 1.41 2.9K 9,167
2019-06-17 TCHELET RONEN Officer M-Exempt A Common Stock 2,083 1.41 2.9K 8,333
2019-04-12 EMALFARB MARK A Director / Officer / 10% Owner M-Exempt A Common Stock 12,500 1.71 21.4K 4,129,487
2019-03-19 Jones Matthew S. Officer D Stock Option 50,000 1.44 72.0K 0
2019-02-12 Tarnok Michael P. Director D Common Stock 0 0.00 188,929
2019-02-12 Rawson Ping Wang Officer D Common Stock 0 0.00 18,500
2019-02-12 Kaye Jack Director D Common Stock 0 0.00 72,707
2019-02-12 HERBST SETH Director D Common Stock 0 0.00 30,000
2019-02-12 Francisco Trust under agreement dated February 28, 1996 10% Owner D Common Stock 0 0.00 3,781,849
2019-02-12 EMALFARB MARK A Director / Officer / 10% Owner I Common Stock 0 0.00 4,116,987
2019-01-02 TCHELET RONEN Officer D Stock Option 60,000 1.39 83.4K 0
2019-01-02 Jones Matthew S. Officer D Stock Option 50,000 1.39 69.5K 0
2019-01-02 EMALFARB MARK A Director / Officer / 10% Owner D Stock Option 300,000 1.87 561.0K 0
2018-01-03 TCHELET RONEN Officer D Stock Option 50,000 1.63 81.5K 0
2018-01-03 Jones Matthew S. Officer D Stock Option 40,000 1.63 65.2K 0
2018-01-02 EMALFARB MARK A Director / Officer / 10% Owner D Stock Option 270,000 1.39 375.3K 0
2017-01-03 EMALFARB MARK A Director / Officer / 10% Owner D Stock Option 150,000 1.63 244.5K 0
2015-12-31 Tarnok Michael P. Director D Stock Option 16,875 1.36 23.0K 0
2015-12-31 TCHELET RONEN Officer D Stock Option 60,417 1.41 85.2K 0
2015-12-31 Kaye Jack Director D Stock Option 22,500 1.33 29.9K 0
2015-12-31 KITT BARRY M 10% Owner I Common stock, $0.001 par value per share 0 0.00 4,363,589
2015-12-31 HERBST SETH Director D Stock Option 14,062 1.76 24.7K 0
2015-12-31 EMALFARB MARK A Director / Officer / 10% Owner D Stock Option 37,500 1.71 64.1K 0
2015-02-28 HERBST SETH Director D Stock Option 9,375 1.93 18.1K 0
2008-12-16 KITT BARRY M 10% Owner P-Purchase A Common Stock, Par Value $0.001 per share 1,500 0.15 225.00 1,959,172
2008-12-15 KITT BARRY M 10% Owner P-Purchase A Common Stock, Par Value $0.001 per share 6,200 0.15 930.00 1,957,672
2008-12-12 KITT BARRY M 10% Owner P-Purchase A Common Stock, Par Value $0.001 per share 54,500 0.15 8.2K 1,951,472
2008-12-11 KITT BARRY M 10% Owner P-Purchase A Common Stock, Par Value $0.001 per share 10,300 0.15 1.5K 1,896,972
2008-12-10 KITT BARRY M 10% Owner P-Purchase A Common Stock, Par Value $0.001 per share 1,900 0.15 285.00 1,886,672
2008-12-09 KITT BARRY M 10% Owner P-Purchase A Common Stock, par value $0.001 per share 300 0.15 45.00 1,884,772
2008-12-08 KITT BARRY M 10% Owner P-Purchase A Common Stock, par value $0.001 per share 25,700 0.15 3.9K 1,884,472
2008-12-05 KITT BARRY M 10% Owner P-Purchase A Common Stock, par value $0.001 per share 9,000 0.15 1.4K 1,858,772
2008-12-04 KITT BARRY M 10% Owner P-Purchase A Common Stock, par value $0.001 per share 8,900 0.15 1.3K 1,849,772
2008-12-03 KITT BARRY M 10% Owner P-Purchase A Common Stock, par value $0.001 per share 7,200 0.10 720.00 1,840,872
2008-12-02 KITT BARRY M 10% Owner P-Purchase A Common Stock, par value $0.001 per share 19,700 0.10 2.0K 1,833,672
2008-11-17 KITT BARRY M 10% Owner P-Purchase A Common Stock, par value $0.001 per share 23,400 0.20 4.6K 1,813,972
2007-10-31 KNOTT DAVID M 10% Owner I Common Stock, $0.001 par value per share 0 0.00 0
2007-10-31 KITT BARRY M 10% Owner I Warrants to purchase shares of Common Stock 68,700 6.33 434.9K 0
2007-10-31 Juda Tom 10% Owner I Common Stock, par value $0.001 per share 0 0.00 395,100
2007-10-31 Emerson Steve 10% Owner I Common Stock, par value $0.001 per share 0 0.00 72,500
2007-04-23 DELA POINTE LISA M Officer D Incentive Stock Option 15,000 4.60 69.0K 0
2007-04-05 SPROAT KENT MICHAEL Officer A-Award A Incentive Stock Option 30,000 5.80 174.0K 150,000
2007-04-05 Nedwin Glenn E Officer A-Award A Incentive Stock Option 35,000 5.80 203.0K 1,147,555

Executive team

Top executives
EBIT / Employee
-11.9K
Shares Outstanding
36.44M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Mark A. Emalfarb CEO and Director 612.4K 173.6K 192.2K 26.9K 1.01M 19.12%
2 2025 Joseph Hazelton President and Chief Operating Officer 307.4K 61.6K 100.3K 14.0K 483.3K 20.75%
3 2025 Ping Rawson Chief Financial Officer 278.4K 49.3K 72.1K 13.3K 413.2K 17.45%
4 2024 Mark A. Emalfarb CEO and Director 586.0K 229.0K 198.1K 26.7K 1.04M 19.05%
5 2024 Mark A. Emalfarb President, CEO and Director 586.0K 229.0K 198.1K 26.7K 1.04M 19.05%
6 2024 Joseph Hazelton Chief Operating Officer 273.0K 94.5K 97.4K 13.3K 478.2K 20.37%
7 2024 Joseph Hazelton President and Chief Operating Officer 273.0K 94.5K 97.4K 13.3K 478.2K 20.37%
8 2024 Ping W. Rawson Chief Financial Officer 266.4K 65.1K 74.3K 13.3K 419.1K 17.73%
9 2024 Ping Rawson Chief Financial Officer 266.4K 65.1K 74.3K 13.3K 419.1K 17.73%
10 2023 Mark A. Emalfarb President, CEO and Director 568.9K 268.4K 169.9K 26.1K 1.03M 16.44%
11 2023 Joseph Hazelton Chief Operating Officer 254.3K 89.6K 79.6K 10.2K 433.7K 18.36%
12 2023 Ping W. Rawson Chief Financial Officer 258.7K 76.0K 63.7K 10.4K 408.7K 15.59%
13 2022 Mark A. Emalfarb President, CEO and Director 546.0K 256.6K 544.4K 25.1K 1.37M 39.68%
14 2022 Ping W. Rawson Chief Financial Officer 248.3K 72.9K 207.9K 12.2K 541.3K 38.41%
15 2022 Joseph Hazelton Chief Business Officer 241.6K 27.2K 79.3K 34.7K 8.1K 390.8K 29.15%
16 2022 Joseph Hazelton Chief Operating Officer 241.6K 106.5K 34.7K 8.1K 390.8K 8.87%
17 2021 Mark A. Emalfarb President, CEO and Director 525.0K 210.0K 531.2K 24.5K 1.29M 41.15%
18 2021 Matthew Jones Managing Dir. of Bus. Dev and Licensing 309.8K 23.2K 187.2K 520.2K 35.98%
19 2021 Ping W. Rawson Chief Financial Officer 238.7K 59.7K 199.2K 11.6K 509.2K 39.12%
20 2021 Ping Rawson Chief Financial Officer 238.7K 59.7K 199.2K 11.6K 509.2K 39.12%
21 2021 Ronen Tchelet, Ph.D. VP of Research and Business Development 232.8K 22.5K 168.5K 423.7K 39.76%
22 2021 Joseph Hazelton Chief Business Officer 34.5K 12.0K 46.5K 0.00%
23 2020 Mark A. Emalfarb President, CEO and Director 500.0K 200.0K 657.3K 24.3K 1.38M 47.58%
24 2020 Matthew Jones Managing Dir. of Bus. Dev and Licensing 276.4K 88.9K 154.3K 519.6K 29.70%
25 2020 Matthew S. Jones Managing Dir. of Bus. Dev and Licensing 276.4K 88.9K 154.3K 519.6K 29.70%
26 2020 Ping W. Rawson Chief Financial Officer 231.8K 57.9K 164.3K 11.4K 465.4K 35.31%
27 2020 Ping Rawson Chief Financial Officer 231.8K 57.9K 164.3K 11.4K 465.4K 35.31%
28 2020 Ronen Tchelet, Ph.D. VP of Research and Business Development 217.9K 42.1K 154.3K 414.2K 37.25%
29 2019 Mark A. Emalfarb President, CEO and Director 440.0K 250.0K 156.0K 228.0K 1.07M 14.52%
30 2019 Matthew S. Jones Managing Dir. of Bus. Dev and Licensing 269.5K 83.0K 57.0K 409.4K 13.92%
31 2019 Ping W. Rawson Chief Financial Officer 220.0K 56.3K 114.3K 8.8K 399.3K 28.61%
32 2019 Ronen Tchelet, Ph.D. VP of Research and Business Development 207.6K 41.2K 57.0K 305.8K 18.64%
33 2018 Mark A. Emalfarb President, CEO and Director 393.0K 200.0K 99.9K 468.9K 1.16M 8.60%
34 2018 Matthew S. Jones Managing Dir. of Bus. Dev and Licensing 273.1K 40.0K 313.1K 12.78%
35 2018 Ronen Tchelet, Ph.D. VP of Research and Business Development 212.3K 23.4K 11.8K 247.5K 9.46%
36 2018 Ping W. Rawson Chief Accounting Officer 199.8K 34.6K 8.0K 242.4K 14.28%
37 2018 Ping W. Rawson Chief Financial Officer 199.8K 34.6K 8.0K 242.4K 14.28%
38 2017 Mark A. Emalfarb President, CEO and Director 382.0K 120.0K 655.0K 1.16M 10.37%
39 2017 Matthew S. Jones Managing Dir. of Bus. Dev and Licensing 256.4K 33.2K 289.6K 11.46%
40 2017 Ronen Tchelet, Ph.D. VP of Research and Business Development 200.5K 41.5K 6.1K 248.1K 16.73%
41 2005 Mark A. Emalfarb Chairman, President and Chief Executive Officer 300.0K 300.0K 0.00%
42 2005 Wayne Moor Chief Financial Officer and Vice President 207.1K 307.9K 207.1K 148.65%
43 2005 Kent M. Sproat Executive Vice President, Enzyme Business 179.2K 30.0K 179.2K 16.75%
44 2005 Ratnesh (Ray) Chandra Senior Vice President, Marketing - Biotechnology Systems 165.5K 30.0K 165.5K 18.13%
45 2005 Alexander (Sasha) Bondar Vice President, Strategy Corporate Development 139.8K 20.0K 139.8K 14.31%
46 2004 Mark A. Emalfarb Chairman, President and Chief Executive Officer 300.0K 75.0K 375.0K 0.00%
47 2004 Ratnesh (Ray) Chandra Senior Vice President, Marketing - Biotechnology Systems 149.9K 30.0K 60.0K 179.9K 33.36%
48 2004 Kent M. Sproat Executive Vice President, Enzyme Business 145.2K 30.0K 80.0K 175.2K 45.66%
49 2004 Alexander (Sasha) Bondar Vice President, Strategy Corporate Development 138.1K 25.0K 45.0K 163.1K 27.59%
50 2003 Mark A. Emalfarb Chairman, President and Chief Executive Officer 300.0K 36.0K 336.0K 0.00%
51 2003 Ratnesh (Ray) Chandra Senior Vice President, Marketing - Biotechnology Systems 144.0K 23.3K 15.0K 167.3K 8.97%
52 2003 Kent M. Sproat Executive Vice President, Enzyme Business 139.5K 23.3K 10.0K 162.8K 6.14%
53 2003 Alexander (Sasha) Bondar Vice President, Strategy Corporate Development 74.2K 23.3K 25.0K 97.4K 25.67%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-05-12 DEF 14A
2026-05-01 PRE 14A
2025-04-29 DEFA14A
2025-04-29 DEF 14A
2024-04-24 DEFA14A
2024-04-24 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-13 8-K
2026-05-13 10-Q
2026-05-12 DEF 14A
2026-05-11 SC 13G/A
2026-05-11 SC 13G
2026-05-01 PRE 14A
2026-04-30 10-K/A
2026-03-30 8-K
2026-03-25 8-K
2026-03-25 10-K

Executive team

NameTitleCompensationGender
Mark A. Emalfarb Founder, Chief Executive Officer & Director 812.9K male
Joseph Hazelton President & Chief Operating Officer 383.0K male
Ping Wang Rawson Chief Financial Officer 344.8K female
Ana Gómez Rodriguez Secretary of the Board female
ESG Rating
B
BIOTECHNOLOGY
Rank: 397 out of 662
2026
E (Environmental)
68.4 / 56.3
Company / Sector avg.
S (Social)
75.2 / 62.4
Company / Sector avg.
G (Governance)
64.0 / 60.9
Company / Sector avg.
ESG Total
69.2 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits